BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 8471899)

  • 1. Treating acute urinary tract infections. An RCT of 3-day versus 7-day norfloxacin.
    Trienekens TA; London NH; Houben AW; De Jong RA; Stobberingh EE
    Can Fam Physician; 1993 Mar; 39():514-8. PubMed ID: 8471899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-dose compared with 3-day norfloxacin treatment of uncomplicated urinary tract infection in women. Canadian Infectious Diseases Society Clinical Trials Study Group.
    Saginur R; Nicolle LE
    Arch Intern Med; 1992 Jun; 152(6):1233-7. PubMed ID: 1599352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter comparative trial of three-day norfloxacin vs ten-day sulfamethoxazole and trimethoprim for the treatment of uncomplicated urinary tract infections.
    Stein GE; Mummaw N; Goldstein EJ; Boyko EJ; Reller LB; Kurtz TO; Miller K; Cox CE
    Arch Intern Med; 1987 Oct; 147(10):1760-2. PubMed ID: 3310941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Norfloxacin in the treatment of urinary tract infections].
    Joost J
    Wien Klin Wochenschr; 1986 May; 98(11):355-7. PubMed ID: 3524016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-dose ciprofloxacin versus 3 days of norfloxacin in uncomplicated urinary tract infections in women.
    Auquer F; Cordón F; Gorina E; Caballero JC; Adalid C; Batlle J;
    Clin Microbiol Infect; 2002 Jan; 8(1):50-4. PubMed ID: 11906502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressive therapy with norfloxacin in patients with recurrent and/or complicated urinary tract infection.
    Falck L; Bucht H; Stegmayr B; Svärd R
    Scand J Urol Nephrol Suppl; 1988; 110():307-11. PubMed ID: 3055255
    [No Abstract]   [Full Text] [Related]  

  • 7. Randomized double-blind trial of high- and low-dose fleroxacin versus norfloxacin for complicated urinary tract infection.
    Pittman W; Moon JO; Hamrick LC; Cox CE; Clark J; Childs S; Pizzuti D; Fredericks J; St Clair P
    Am J Med; 1993 Mar; 94(3A):101S-104S. PubMed ID: 8452163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Norfloxacin: a three-day course for the treatment of urinary tract infection.
    Ganguli LA; Keaney MG; Gould LJ
    Drugs Exp Clin Res; 1985; 11(3):177-9. PubMed ID: 3836125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fleroxacin versus norfloxacin for oral treatment of serious urinary tract infections.
    Childs SJ
    Am J Med; 1993 Mar; 94(3A):105S-107S. PubMed ID: 8452164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose norfloxacin versus placebo for long-term prophylaxis of recurrent uncomplicated urinary tract infection.
    Rugendorff E; Haralambie E
    Chemioterapia; 1987 Jun; 6(2 Suppl):533-5. PubMed ID: 3334616
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of uncomplicated recurrent cystitis in women: lomefloxacin versus norfloxacin].
    Guibert J; Herman H; Capron MH
    Contracept Fertil Sex; 1997 Jan; 25(1):79-84. PubMed ID: 9064058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind controlled trial of norfloxacin versus cotrimoxazole in the treatment of urinary tract infections.
    Chan MK; Wong WT; Cheng IK
    Br J Clin Pract; 1989 Feb; 43(2):61-3. PubMed ID: 2679836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of norfloxacin 800 mg once-daily versus norfloxacin 400 mg twice-daily in the treatment of uncomplicated urinary tract infections in women: a double-blind, randomized clinical trial.
    Pimentel FL; Dolgner A; Guimarães J; Quintas M; Mário-Reis J
    J Chemother; 1998 Apr; 10(2):122-7. PubMed ID: 9603637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interpretation of the bacteriologic outcome of antibiotic treatment for uncomplicated cystitis: impact of the definition of significant bacteriuria in a comparison of ritipenem acoxil with norfloxacin. Swedish Urinary Tract Infection Study Group.
    Clin Infect Dis; 1995 Mar; 20(3):507-13. PubMed ID: 7756468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of brodimoprim od versus norfloxacin bid in the treatment of bacterial urinary tract infections.
    Scaglione F; Demartini G; Cocuzza C; Raschi S; Cogo R
    Int J Clin Pharmacol Res; 1995; 15(3):121-5. PubMed ID: 8847153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Norfloxacin versus nalidixic acid in the treatment of urinary tract infections.
    Karachalios GN; Georgiopoulos AN
    Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):317-9. PubMed ID: 3623736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case report of renal failure during norfloxacin therapy.
    Boelaert J; de Jaegere PP; Daneels R; Schurgers M; Gordts B; van Landuyt HW
    Clin Nephrol; 1986 May; 25(5):272. PubMed ID: 3522001
    [No Abstract]   [Full Text] [Related]  

  • 18. A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection.
    Iravani A; Klimberg I; Briefer C; Munera C; Kowalsky SF; Echols RM
    J Antimicrob Chemother; 1999 Mar; 43 Suppl A():67-75. PubMed ID: 10225575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Norfloxacin versus parenteral therapy in the treatment of complicated urinary tract infections and resistant organisms.
    Cherubin C; Stilwell S
    Scand J Infect Dis Suppl; 1986; 48():32-7. PubMed ID: 3535053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of norfloxacin in complicated and recurrent urinary tract infections.
    Schaeffer AJ
    Eur Urol; 1990; 17 Suppl 1():19-23. PubMed ID: 2191865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.